Related Experiment Video
Updated: Jul 25, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Targeted temperature management at 36°C is a risk factor for ventilator-associated pneumonia
Masaru Nasuno1,2, Yukari Yokoyama3, Mitsuo Motobayashi2,4,5,6
1Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.
Insights
Therapeutic normothermia at 36°C and methylprednisolone pulse therapy are potential risk factors for ventilator-associated pneumonia (VAP) in children. This study highlights key factors contributing to VAP in pediatric patients requiring mechanical ventilation.
Area of Science:
- Pediatric critical care medicine
- Infectious disease epidemiology
- Respiratory medicine
Background:
- Limited data exists on ventilator-associated pneumonia (VAP) risk factors in children.
- Therapeutic hypothermia is a known VAP risk factor in adults, but the role of normothermia is unclear.
- This study focuses on identifying VAP risk factors in pediatric patients, specifically examining therapeutic normothermia's impact.
Purpose of the Study:
- To investigate risk factors for ventilator-associated pneumonia (VAP) in children.
- To evaluate the association between therapeutic normothermia and VAP onset in pediatric patients.
- To identify specific interventions that may increase VAP risk in mechanically ventilated children.
Main Methods:
- Retrospective analysis of clinical characteristics in children mechanically ventilated for over 48 hours.
- VAP onset defined as occurring within seven days of mechanical ventilation initiation.
- Statistical analysis including univariate analysis, Kaplan-Meier plots, and log-rank tests to identify risk factors.
Main Results:
- Seven out of 288 (2.4%) pediatric patients developed VAP.
- No significant differences in clinical backgrounds were found between VAP and non-VAP groups.
- Therapeutic temperature management (TTM) at 36°C and methylprednisolone (mPSL) pulse therapy were identified as significant risk factors for VAP.
Conclusions:
- Therapeutic temperature management (TTM) at 36°C may increase the risk of VAP in pediatric patients.
- Methylprednisolone (mPSL) pulse therapy is a potential risk factor for VAP in the pediatric population.
- These findings suggest a need to reconsider temperature management protocols and corticosteroid use in mechanically ventilated children to prevent VAP.
Background:
In contrast to the adult population, limited information is currently available on risk factors for ventilator-associated pneumonia (VAP) in children. Therapeutic hypothermia has been identified as a risk factor for the early onset of VAP in adults; however, the relationship between VAP and normothermia remains unclear. The present study investigated risk factors for VAP in children, with a focus on the deleterious effects of therapeutic normothermia on VAP.
Methods:
We retrospectively investigated the clinical characteristics of children treated with mechanical ventilation for more than 48 h and analyzed risk factors for VAP. The endpoint was the onset of VAP by the seventh day after the initiation of mechanical ventilation.
Results:
Among the 288 patients enrolled, seven (2.4%) developed VAP. No significant differences were observed in clinical backgrounds between the VAP and non-VAP groups. A univariate analysis identified target temperature management (TTM) at 36°C (p < 0.0001) and methylprednisolone (mPSL) pulse therapy (p = 0.02) as risk factors for VAP. An analysis of the time to the onset of VAP by the Kaplan-Meier plot and log-rank test revealed a significantly higher incidence of VAP in the TTM group (p < 0.0001) and mPSL pulse group (p = 0.001).
Conclusion:
TTM at 36°C and mPSL pulse therapy may be risk factors for VAP in the pediatric population.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Increased Body Temperature
Factors Affecting Body Temperature
Factors may include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Decreased Body Temperature

